The decline in sales of new generation pills continues. IUDs and implants are experiencing a real boom, with an increase of 28% in March 2013 compared to March 2012.
The era of the all pill may be over. Indeed, according to the second analysis of usage data from the National Council of the Order of Pharmacists (CNOP) and Celtipharm, published today by the Medicines Agency (Ansm), the sharp increase in sales of implants and IUDs continued: + 28% in March 2013 compared to March 2012. Devices not impregnated with progestins saw the greatest increase: + 42% for the same period compared. For years, information campaigns have encouraged women to choose the contraception that is right for them, and not necessarily the pill. The alerts on 3rd and 4th generation pills may help achieve this goal.
Regarding pills, the figures on the sales of these contraceptives in France follow one another and are similar. Thus, for sales of combined oral contraceptives (COCs) of 3th and 4th generation, the decrease is confirmed at the beginning of the year: -37% in March 2013 compared to March 2012. This fall is accompanied this time again by a significant increase in the use of 1st and 2nd COCsth generation: + 22% (still for the same period). The Ansm, which recommended that doctors prescribe 1st and 2nd generation pills as the first line, therefore seems to be well listened to by professionals.
Finally, over the period from December 2012 to March 2013, a drop in sales of COCs, all generations combined was observed: -1.9% compared to the same period of the previous year and -2.9% if the anti-acne Diane 35 is taken into account in the overall contraception. “This drop is not more significant among young women aged 15 to 19,” said the Agency. As part of its action plan on COCs, Ansm regularly publishes new data available on the evolution of practices related to the use of contraceptives in France.
.
